Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Insulin delivery device"'
Publikováno v:
Medical Devices: Evidence and Research, Vol Volume 13, Pp 283-291 (2020)
Ripu Hundal,1 Stephan Kowalyk,2 Amanda Wakim,3 Carla Nikkel,4 John H Sink II,4 Melissa Doyle5 1First State Endocrinology, Newark, DE, USA; 2Endocrinology Specialists PC, Greensburg, PA, USA; 3Center of Endocrinology, Wheeling Hospital, Wheeling, WV,
Externí odkaz:
https://doaj.org/article/bb1bbf8f0b9d4a429bec60992ef3084d
Autor:
Carla C. Nikkel, Melissa Doyle, John H. Sink, Ripu S. Hundal, Amanda P. Wakim, Stephan Kowalyk
Publikováno v:
Medical Devices (Auckland, N.Z.)
Ripu Hundal,1 Stephan Kowalyk,2 Amanda Wakim,3 Carla Nikkel,4 John H Sink II,4 Melissa Doyle5 1First State Endocrinology, Newark, DE, USA; 2Endocrinology Specialists PC, Greensburg, PA, USA; 3Center of Endocrinology, Wheeling Hospital, Wheeling, WV,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::527bf22d54a358ec118656650c392bbc
https://doi.org/10.2147/mder.s265869
https://doi.org/10.2147/mder.s265869
Autor:
Edward T. Mahoney, Drilon Saliu, David Sze, Ronnie Aronson, Didier Morel, Laurence J. Hirsch, Leya Bergquist
Publikováno v:
Diabetes Technology & Therapeutics
Background: This study undertook to assess usability, 24-h glycemic profiles, and safety of an investigational basal/bolus insulin delivery device (IDD) providing rapid-acting or regular human insulin (RHI) for people with type 2 diabetes (T2D) trans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df3021e566a8de26ef7565507ac07b61
https://doi.org/10.1089/dia.2019.0356
https://doi.org/10.1089/dia.2019.0356
Autor:
Lisa T. Meade, Dawn Battise
Publikováno v:
Clin Diabetes
Uncontrolled type 2 diabetes can lead to a multitude of health complications. Insulin therapy is recommended when patients are unable to reach their A1C goal with oral or noninsulin injectable diabetes medications. This study evaluated the clinical b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e231cf3840136a5b880d01fedf29ecc
https://europepmc.org/articles/PMC8329021/
https://europepmc.org/articles/PMC8329021/
Autor:
H. Courtenay Harrison, Leon Shi, Mark J. Cziraky, Matt Nguyen, Scott D Abbott, T. Wasser, Lynn Nowak, Beverly Everitt, Elizabeth Apgar, Kay Larholt, Poul Strange
Publikováno v:
Journal of Health Economics and Outcomes Research
Background: Many patients with type 2 diabetes mellitus (T2DM) do not have adequate glycemic control, leading to poor patient outcomes and high healthcare costs. Objective: This prospective pragmatic clinical trial evaluated V-Go, a wearable insulin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fff2d070be307ce01ef7b4d58ec1bf2c
https://doi.org/10.36469/9731
https://doi.org/10.36469/9731
Publikováno v:
Pharmacy
Volume 8
Issue 4
Pharmacy, Vol 8, Iss 215, p 215 (2020)
Volume 8
Issue 4
Pharmacy, Vol 8, Iss 215, p 215 (2020)
Insulin therapy is frequently required to achieve glycemic targets (A1c) in type 2 diabetes (T2D)
however, clinicians and patients face barriers with the complexities of multiple daily injection regimens. Patch-like wearable insulin devices, suc
however, clinicians and patients face barriers with the complexities of multiple daily injection regimens. Patch-like wearable insulin devices, suc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5423680cb4b26f0aac98b5321bcb6eff
Autor:
Thomas R. Pieber, M Trautmann, D. Johns, Felix Aberer, Jay Warner, Tina Poettler, Julia K. Mader, Leslie C. Lilly
Publikováno v:
Diabetic Medicine
Aim To evaluate the PAQ ® (CeQur SA, Horw, Switzerland), a wearable 3‐day insulin delivery device that provides set basal rates and bolus insulin on demand, in people with Type 2 diabetes. Method Adults with Type 2 diabetes with HbA1c concentratio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7c4fc0a93e074b925bb5c857d10112d
http://europepmc.org/articles/PMC6175230
http://europepmc.org/articles/PMC6175230
Publikováno v:
Diabetes. 68
A stepwise approach for the addition of prandial insulin is recommended when intensification from basal to basal-bolus therapy is required. Rationale for this approach includes patient resistance to multiple daily injections and a stepwise approach h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abfb425db5aa6f0afe48600c0c97805b
https://doi.org/10.2337/db19-1044-p
https://doi.org/10.2337/db19-1044-p
Autor:
Ayad K. Ali, Melissa Ewing
Publikováno v:
Diabetes. 68
This study evaluated the impact of additional risk minimization measures on healthcare professional (HCP) and patient understanding and behavior regarding the risk of hypoglycemia and/or hyperglycemia due to medication errors associated with administ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c5dc0abdabb27361e81802ce6eb08c4
https://doi.org/10.2337/db19-2324-pub
https://doi.org/10.2337/db19-2324-pub
Publikováno v:
Diabetes. 68
Basal-bolus insulin therapy in older patients is challenging due to the complexities of multiple daily injections and the higher risk of adverse consequences associated with hypoglycemia in this population. The purpose of this analysis was to evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::091fc5a49ffc2f8fcde4dc54837acf3a
https://doi.org/10.2337/db19-1045-p
https://doi.org/10.2337/db19-1045-p